Results 51 to 60 of about 27,891 (280)
Skin rash and mild bruising: Is montelukast a safe drug?
Montelukast is one of the commonly used drugs in asthma patients. It is prescribed along with inhalational corticosteroids. Although a relatively safe drug, there is a probability of occurrence of skin rashes and skin bruising.
Deep Inder+3 more
doaj +1 more source
Leukotriene antagonists as first-line or add-on asthma controller therapy [PDF]
Most randomized trials of treatment for asthma study highly selected patients under idealized conditions. METHODS: We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist ...
Annie Blyth+22 more
core +1 more source
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
Currently, there is no definitive cure for epilepsy. The available medications relieve symptoms and reduce seizure attacks. The major challenge with the available antiepileptic medication is safety and affordability.
B. Tesfaye+4 more
semanticscholar +1 more source
Photochemical anaerobic oxidation of sulfides, using nitroarenes as bifunctional reagents, enables the formal manipulation of the C─S bond. The method allows direct and selective access to versatile carbonyl compounds from largely inert sulfides by C–H oxidation, thus avoiding multistep activation by sulfur oxidation.
Valentina D. Cuomo+2 more
wiley +2 more sources
Montelukast is a leukotriene receptor antagonist that is known to prevent allergic rhinitis and asthma. Blocking the Cysteinyl leukotriene receptor (CysLTR1), one of the primary receptors of leukotrienes, has been demonstrated to be efficacious in ...
B. Han+12 more
semanticscholar +1 more source
A highly stereoselective, dynamic reductive kinetic resolution (DYRKR) entry into myriad Taxotere‐like side chains with Clostridium acetobutylicum alcohol dehydrogenase (CaADH) enzyme is reported. Follow‐on cross couplings expand the structural diversity of the library (36 total examples).
Gaurav P. Kudalkar+15 more
wiley +2 more sources
Montelukast in hospitalized patients diagnosed with COVID-19
Objective Several therapeutic agents have been assessed for the treatment of COVID-19, but few approaches have been proven efficacious. Because leukotriene receptor antagonists, such as montelukast have been shown to reduce both cytokine release and lung
Ahsan Khan+15 more
semanticscholar +1 more source
Nonesophageal Eosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions [PDF]
Eosinophilic gastrointestinal disorders are a set of conditions with a wide range of clinical manifestations and treatment modalities. The disorders are suspected to result from an abnormal inflammatory response to allergen(s), and individuals may ...
Gupta, Sandeep K., Naramore, Sara
core +1 more source
Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review
Background Eosinophilic gastrointestinal disorders, also known as eosinophilic gastroenteritis, are rare inflammatory conditions characterized by eosinophilic infiltration of different parts of the gastrointestinal tract, along with peripheral ...
Emran El-Alali+2 more
semanticscholar +1 more source
Concentrations of Cysteinyl Leukotrienes in Various Biological Fluids of Children with Bronchial Asthma, Atopic Dermatitis and Food Protein Induced Enterocolitis [PDF]
Clinical manifestation of food allergy is characterized by polymorphic cutaneous, respiratory and gastrointestinal syndromes. Leukotrienes occupy a key place in the pathogenesis of a wide range of inflammatory diseases, including bronchial asthma ...
Haiduchyk, H. (Halyna)+1 more
core +4 more sources